TherapeuticsMD (TXMD) Misses Q1 EPS by 2c

TherapeuticsMD (NYSE: TXMD) reported Q1 EPS of ($0.11), $0.02 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $4.93 million versus the consensus estimate of $5.73 million.

For earnings history and earnings-related data on TherapeuticsMD (TXMD) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Ennis (EBF) Reports In-Line Q1 EPS
• CVG to join Russell 2000 and Russell 3000 indexes June 26